Metabolic engineering of Agrobacterium sp. strain ATCC 31749 for production of an α-Gal epitope

Microbial Cell Factories

Volumn 9, Issue , 2010, Pages

  Ruffing, Anne M ^a   Chen, Rachel R ^a  

^a Georgia Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURDLAN; GALACTOSE; GALACTOSYLGALACTOSE; LACTOSE PERMEASE; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE; 1,3 ALPHA GLUCAN SYNTHASE; 1,3-ALPHA-D-GLUCAN SYNTHASE; EPITOPE; GLUCOSYLTRANSFERASE; HYBRID PROTEIN;

ARTICLE; BACTERIAL STRAIN; BIOCATALYST; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE TRANSPORT; METABOLIC ENGINEERING; NONHUMAN; PROTEIN EXPRESSION; RHIZOBIUM; CHEMISTRY; ENZYME SPECIFICITY; GENETIC ENGINEERING; GENETICS; METABOLISM;

AGROBACTERIUM; AGROBACTERIUM SP.; AGROBACTERIUM SP. ATCC 31749;

EPITOPES; GENETIC ENGINEERING; GLUCOSYLTRANSFERASES; RECOMBINANT FUSION PROTEINS; RHIZOBIUM; SUBSTRATE SPECIFICITY;

EID: 76749163736     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-9-1     Document Type: Article

References (28)

1. Macher BA, Galili U. The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochimica et Biophysica Acta 2008, 1780(2):75-88. 2271034, 18047841.
2. Galili U. The α-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunology and Cell Biology 2005, 83:674-686. 10.1111/j.1440-1711.2005.01366.x, 16266320.
3. Chen X, Andreana PR, Wang PG. Carbohydrates in transplantation. Current Opinion in Chemical Biology 1999, 3:650-658. 10.1016/S1367-5931(99)00022-8, 10600719.
4. Abdel-Motal UM, Guay HM, Wigglesworth K, Welsh RM, Galili U. Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells. Journal of Virology 2007, 81:9131-9141. 10.1128/JVI.00647-07, 1951452, 17609270.
5. Abdel-Motal UM, Wang S, Lu S, Wigglesworth K, Galili U. Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galα1-3Gal β1-4GlcNAc-R epitopes. Journal of Virology 2006, 80:6943-6951. 10.1128/JVI.00310-06, 1489031, 16809300.
6. LaTemple DC, Abrams JT, Zhang SU, Galili U. Increased immunogenicity of tumor vaccines complexted with anti-Gal: studies in knock out mice for α1,3galactosyltransferase. Cancer Research 1999, 59:3417-3423.
7. Galili U, Wigglesworth K, Abdel-Motal UM. Intratumoral injection of α-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines. Journal of Immunology 2007, 178:4676-4687.
8. Chen X, Zhang W, Wang J, Fang J, Wang PG. Production of α-galactosyl epitopes via combined use of two recombinant whole cells harboring UDP-galactose 4-epimerase and α-1,3-galactosyltransferase. Biotechnology Progress 2000, 16:595-599. 10.1021/bp000052s, 10933834.
9. Fang J, Chen X, Zhang W, Janczuk A, Wang PG. Synthesis of α-Gal epitope derivatives with a galactosyltransferase-epimerase fusion enzyme. Carbohydrate Research 2000, 329:873-878. 10.1016/S0008-6215(00)00245-7, 11125830.
10. Hokke CH, Zervosen A, Elling L, Joziasse DH, Eijnden DH. One-pot enzymatic synthesis of the Galα1→3Galβ1→4GlcNAc sequence with in situ UDP-Gal regeneration. Glycoconjugate Journal 1996, 13:687-692. 10.1007/BF00731458, 8872127.
11. Fang J, Li J, Chen X, Zhang Y, Wang J, Guo Z, Zhang W, Yu L, Brew K, Wang PG. Highly efficient chemoenzymatic synthesis of α-galactosyl epitopes with a recombinant α(1→3)-galactosyltransferase. Journal of the American Chemical Society 1998, 120(27):6635-6638.
12. Chen X, Liu Z, Zhang J, Zhang W, Kowal P, Wang PG. Reassembled biosynthetic pathway for large-scale carbohydrate synthesis: α-Gal epitope producing "superbug". ChemBioChem 2002, 3:47-53. 10.1002/1439-7633(20020104)3:1<47::AID-CBIC47>3.0.CO;2-N, 17590953.
13. Shao J, Hayashi T, Wang PG. Enhanced production of α-galactosyl epitopes by metabolically engineered Pichia pastoris. Applied and Environmental Microbiology 2003, 69(9):5238-5242. 10.1128/AEM.69.9.5238-5242.2003, 194961, 12957908.
14. Bettler E, Imberty A, Priem B, Chazalet V, Heyraud A, Joziasse DH, Geremia RA. Production of recombinant xenotransplantation antigen in Escherichia coli. Biochemical and Biophysical Research Communications 2003, 302:620-624. 10.1016/S0006-291X(03)00227-4, 12615080.
15. Ruffing A, Mao Z, Chen RR. Metabolic engineering of Agrobacterium sp. for UDP-galactose regeneration and oligosaccharide synthesis. Metabolic Engineering 2006, 8:465-473. 10.1016/j.ymben.2006.05.004, 16890004.
16. Gorke B, Stulke J. Carbon catabolite repression in bacteria: many ways to make the most out of nutrients. Nature Reviews Microbiology 2008, 6(8):613-624. 10.1038/nrmicro1932, 18628769.
17. Chen X, Liu Z, Wang J, Fang J, Fan H, Wang PG. Changing the donor cofactor of bovine α1,3-galactosyltransferase by fusion with UDP-galactose 4-epimerase. The Journal of Biological Chemistry 2000, 275(41):31594-31600. 10.1074/jbc.M004005200, 10913140.
18. Abramson J, Smirnova I, Kasho V, Verner G, Iwata S, Kaback HR. The lactose permease of Escherichia coli: overall structure, the sugar-binding site and the alternating access model for transport. FEBS Letters 2003, 555(1):96-101. 10.1016/S0014-5793(03)01087-1, 14630326.
19. Phillips KR, Lawford HG. Curdlan: its properties and production in batch and continuous fermentations. Progress in Industrial Microbiology 1983, 18. Amsterdam: Elsevier Scientific Publishing Co, Bushell DE.
20. Karnezis T, Epa VC, Stone BA, Stanisich VA. Topological characterization of an inner membrane (1→3)-β-D-glucan (curdlan) synthase from Agrobacterium sp. strain ATCC 31749. Glycobiology 2003, 13(10):693-706. 10.1093/glycob/cwg093, 12851288.
21. Oberpichler I, Molina I, Neubauer O, Lamparter T. Phytochromes from Agrobacterium tumefaciens: Difference spectroscopy with extracts of wild type and knockout mutants. FEBS Letters 2006, 580:437-442. 10.1016/j.febslet.2005.12.035, 16378606.
22. Nakanishi I, Kimura K, Suzuki T, Ishikawa M, Banno I, Sakane T, Harada T. Demonstration of curdlan-type polysaccharide and some other β-1,3-glucan in microorganisms with aniline blue. The Journal of General and Applied Microbiology 1976, 22:1-11.
23. McIntosh M, Stone BA, Stanisich VA. Curdlan and other bacterial (1→3)-β-D-glucans. Applied Microbiology and Biotechnology 2005, 68:163-173. 10.1007/s00253-005-1959-5, 15818477.
24. Lee JH, Lee IY. Optimization of uracil addition for curdlan (β-1→3-glucan) production by Agrobacterium sp. Biotechnology Letters 2001, 23:1131-1134.
25. Gilewski T, Ragupathi G, Bhuta S, Williams LJ, Musselli C, Zhang XF, Bornmann WG, Spassova M, Bencsath KP, Panageas KS, et al. Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(6):3270-3275. 10.1073/pnas.051626298, 30643, 11248068.
26. Lee IY, Kim MK, Lee JH, Seo WT, Jung JK, Lee YH, Park YH. Influence of agitation speed on production of curdlan by Agrobacterium species. Bioprocess Engineering 1999, 20:283-287.
27. Lee JH, Lee IY, Kim MK, Park YH. Optimal pH control of batch processes for production of curdlan by Agrobacterium species. Journal of Industrial Microbiology & Biotechnology 1999, 23:143-148.
28. Graupner S, Wackernagel W. A broad-host-range expression vector series including a Pt ac test plasmid and its application in the expression of the dod gene of Serratia marcescens (coding for ribulose-5-phosphate 3-epimerase) in Pseudomonas stutzeri. Biomolecular Engineering 2000, 17:11-16. 10.1016/S1389-0344(00)00061-7, 11042472.